Premium Reports
Enterprise Revenue Cycle 2020—Advanced User Insights

Enterprise Revenue Cycle 2020—Advanced User Insights
The Value of Consolidation

September 8, 2020 | Read Time: 8  minutes

Current Time Inside Cache Tag Helper: 11/30/2020 2:04:09 PM and Model.reportId = 1646

While enterprise strategies for clinical technology are common, the complexity of the revenue cycle has, to date, precluded such an approach on the financial side, as no one vendor provides all the revenue cycle functionality organizations need. However, Change Healthcare, Experian, nThrive, and Waystar now claim to have expansive portfolios that fill the gaps left by the EMR and to have customers who have adopted a broad range of their revenue cycle technology. The goal of this report is to validate the veracity of these claims and gain insight into how this early market is shaping up—is enterprise revenue cycle adoption real? Do organizations who have broadly adopted one vendor see valuable benefits?

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 11/30/2020 2:04:09 PM and Model.reportId = 1646

Key Findings

  1. Enterprise Revenue Cycle Not Yet Fully Realized; Change Healthcare, Experian Health Clients Have Adopted Highest Average Number of Component Pieces
  2. Across Vendors, Advanced Users Report Higher Satisfaction Than Non-Enterprise Peers
  3. Advanced Users Still Hesitant to Replace Some High-Performing Best-of-Breed Products
  4. Future of Enterprise Revenue Cycle
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2020 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.